QWM
ZVRA icon

Quaker Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History

Quaker Wealth Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
19,367
+19,167
+9,584% +$213K 0.08% 57
2026
Q1 		$1.86K Sell
200
-1,000
-83% -$9.01K ﹤0.01% 433
2025
Q4 		$10.8K Buy
+1,200
New +$11.3K ﹤0.01% 295

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quaker Wealth Management's ZVRA Position: Q2 2026 in Review

Quaker Wealth Management increased its Zevra Therapeutics (ZVRA) stake by 9,584% in Q2 2026, buying an estimated $213K and bringing the position to 19,367 shares worth $278K. The position accounts for 0.08% of the portfolio, ranked #57.

Quaker Wealth Management first reported a position in ZVRA in Q4 2025 and has held it in 3 quarters since. 158 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Quaker Wealth Management held 19,367 shares of Zevra Therapeutics worth $278K as of Q2 2026.
  • Quaker Wealth Management bought 19,167 Zevra Therapeutics shares in Q2 2026, an estimated $213K.
  • Zevra Therapeutics made up 0.08% of Quaker Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Quaker Wealth Management first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.